By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Keryx Biopharmaceuticals 

750 Lexington Avenue, 26th Floor

New York  New York  10022  U.S.A.
Phone: 212-531-5965 Fax: 212-531-5961


SEARCH JOBS


Industry
Biotechnology






Company News
Keryx Biopharmaceuticals (KERX) Announces Trade Name Auryxia for Ferric Citrate 11/19/2014 9:18:53 AM
Keryx Biopharmaceuticals (KERX) Announces Results From Ferric Citrate Phase 3 Long-Term Safety Extension Study 11/17/2014 10:32:03 AM
Keryx Biopharmaceuticals (KERX) To Present At The Stifel 2014 Healthcare Conference 11/14/2014 10:16:34 AM
Keryx Biopharmaceuticals (KERX) Announces Third Quarter And Nine Month 2014 Financial Results 11/6/2014 10:53:07 AM
Keryx Biopharmaceuticals (KERX) To Host Conference Call On Third Quarter 2014 Financial Results 10/30/2014 8:37:08 AM
Keryx Biopharmaceuticals (KERX) Announces Issuance Of A New U.S. Patent For Ferric Citrate Covering Orally Administrable Forms 10/1/2014 8:55:44 AM
Keryx Biopharmaceuticals (KERX) Initiates Pivotal Phase 3 Study Of Ferric Citrate For The Treatment Of Iron Deficiency Anemia In Patients With Non-Dialysis Dependent Chronic Kidney Disease 9/29/2014 8:57:11 AM
Keryx Biopharmaceuticals (KERX) To Present At The Rodman & Renshaw 16th Annual Global Investment Conference 9/8/2014 7:21:50 AM
FDA Approves Keryx Biopharmaceuticals (KERX)' Kidney Drug Ferric Citrate With Warnings, Shares Crash 9/8/2014 6:25:46 AM
Keryx Biopharmaceuticals (KERX) Announces Second Quarter And Six Month 2014 Financial Results 8/7/2014 8:07:47 AM
12345678910...
//-->